Semaglutide 5mg Dosage & Mixing Guide

What is Semaglutide?

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the effects of the naturally occurring hormone GLP-1. It was developed for research into glucose metabolism, appetite regulation, and metabolic disorders.

The peptide works by binding to GLP-1 receptors, which are found in the pancreas, brain, and gastrointestinal tract. Research has demonstrated effects on insulin secretion, glucagon suppression, gastric emptying, and appetite signaling pathways.

Semaglutide has a significantly extended half-life compared to native GLP-1 (approximately 7 days vs. minutes), allowing for once-weekly administration in research protocols.

Quick Reference

Reconstitution Guide

Materials Needed

• Semaglutide 5mg lyophilized vial
• Bacteriostatic water (BAC water)
• Insulin syringes (U-100, 29-31 gauge)
• Alcohol swabs
• Sharps container

Step-by-Step Instructions

1. Prepare your workspace — Clean your work area and gather all materials. Wash hands thoroughly.

2. Clean the vial stoppers — Wipe the Semaglutide vial stopper and BAC water vial with alcohol swabs. Allow to dry completely.

3. Draw the BAC water — Using a sterile syringe, draw 2mL of bacteriostatic water.

4. Add water to peptide vial — Insert the needle into the Semaglutide vial and slowly inject the BAC water down the inside wall of the vial. Do not spray directly onto the powder.

5. Allow to dissolve — Semaglutide may take 5-10 minutes to fully dissolve. Gently swirl occasionally — never shake vigorously.

6. Verify dissolution — The solution should be completely clear and colorless. If cloudy or particles remain, continue gentle swirling.

7. Label and store — Write the reconstitution date on the vial. Store in refrigerator immediately.

Dosage Protocol

Concentration Calculations

With 5mg peptide in 2mL BAC water:

• Concentration: 2.5mg/mL = 2500mcg/mL
• Per unit (U-100 syringe): 25mcg per unit

Common Dose Calculations

Suggested Titration Protocol

Semaglutide research protocols typically employ gradual dose escalation to assess tolerance:

Important Notes:

• Each dose level should be maintained for at least 4 weeks before escalation
• Not all research protocols require reaching maximum dose
• Dose escalation should be based on research objectives and tolerance

Injection Guide

Subcutaneous Administration

1. Clean the injection site with an alcohol swab
2. Pinch a fold of skin (abdomen, thigh, or upper arm)
3. Insert needle at 90° angle for most body types
4. Inject slowly and steadily
5. Wait 5-10 seconds before withdrawing needle
6. Apply light pressure if needed — do not rub

Site Rotation

Rotate between these areas weekly:

• Abdomen (2+ inches from navel) — most common
• Outer thigh (front/outer area)
• Back of upper arm

Consistency tip: Administer on the same day each week to maintain steady levels.

Storage Requirements

Lyophilized (Powder Form)

• Temperature: -20°C (-4°F) or colder
• Duration: 2+ years
• Conditions: Protect from light and moisture

Reconstituted (Mixed with BAC Water)

• Temperature: 2-8°C (36-46°F) — standard refrigerator
• Duration: 4-6 weeks
• Conditions: Keep away from light, never freeze reconstituted solution

Important Storage Notes

• Semaglutide is sensitive to temperature — minimize time outside refrigeration
• Do not use if solution becomes cloudy, discolored, or contains particles
• Keep track of reconstitution date and discard after 6 weeks maximum

Research Considerations

Mechanism of Action

Semaglutide’s research applications stem from its GLP-1 receptor agonism:

• Pancreatic effects: Glucose-dependent insulin secretion, glucagon suppression
• CNS effects: Appetite regulation via hypothalamic pathways
• GI effects: Delayed gastric emptying
• Cardiovascular: Observed cardioprotective effects in clinical trials

Key Research Findings

Clinical trials (STEP program, SUSTAIN program) have demonstrated:

• Significant effects on body weight in metabolic research
• Improvements in glycemic parameters
• Cardiovascular outcome benefits in at-risk populations

Safety & Handling

General Precautions

• Use sterile technique for all preparations
• Never reuse needles or syringes
• Dispose of sharps properly in designated containers
• Store away from children and unauthorized persons

Research Considerations

• Semaglutide is for research purposes only
• Prescription versions (Ozempic®, Wegovy®) are FDA-approved medications
• Research-grade peptides are not equivalent to pharmaceutical preparations
• Follow institutional guidelines for peptide research

Sourcing for Research

Source from verified suppliers that provide third-party testing and certificates of analysis (COA) for each batch. Compare purity documentation, shipping conditions, and batch traceability before purchasing research materials.

Scientific References

1. Wilding JPH, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” N Engl J Med. 2021;384:989-1002.
2. Marso SP, et al. “Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.” N Engl J Med. 2016;375:1834-1844.
3. Knudsen LB, Lau J. “The Discovery and Development of Liraglutide and Semaglutide.” Front Endocrinol. 2019;10:155.

Last updated: December 01, 2024

Disclaimer: This information is for educational and research purposes only. Semaglutide as a research peptide is not intended for human consumption. Pharmaceutical semaglutide products require a prescription. Always follow applicable laws and institutional guidelines.